Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $305.03 Analyst target: $395.44 Upside: 29.64%
Krystal Biotech, Inc., a clinical-stage biotechnology company, is dedicated to the field of redosable gene therapy to treat serious rare diseases in the United States. The company is headquartered in Pittsburgh, Pennsylvania.
See the full interactive analysis & chart →Informational only — not investment advice.